The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Paul Chapman, Lee D Cranmer, W. G. Dixon, K. L. Hyrich, John R. Patterson, D. P M Symmons, Mary Toporcer, Michael J. Mastrangelo

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalSeminars in Oncology
Volume37
Issue number1
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Antirheumatic Agents
Second Primary Neoplasms
Tumor Necrosis Factor Receptors
Skin Neoplasms
Melanoma
Lung Neoplasms
Rheumatoid Arthritis
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors : Does the Risk Justify the Benefit? / Chapman, Paul; Cranmer, Lee D; Dixon, W. G.; Hyrich, K. L.; Patterson, John R.; Symmons, D. P M; Toporcer, Mary; Mastrangelo, Michael J.

In: Seminars in Oncology, Vol. 37, No. 1, 02.2010, p. 11-19.

Research output: Contribution to journalArticle

Chapman, P, Cranmer, LD, Dixon, WG, Hyrich, KL, Patterson, JR, Symmons, DPM, Toporcer, M & Mastrangelo, MJ 2010, 'The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?', Seminars in Oncology, vol. 37, no. 1, pp. 11-19. https://doi.org/10.1053/j.seminoncol.2010.01.001
Chapman, Paul ; Cranmer, Lee D ; Dixon, W. G. ; Hyrich, K. L. ; Patterson, John R. ; Symmons, D. P M ; Toporcer, Mary ; Mastrangelo, Michael J. / The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors : Does the Risk Justify the Benefit?. In: Seminars in Oncology. 2010 ; Vol. 37, No. 1. pp. 11-19.
@article{dfb18d2f15c64b409bce6971b048f8f5,
title = "The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?",
author = "Paul Chapman and Cranmer, {Lee D} and Dixon, {W. G.} and Hyrich, {K. L.} and Patterson, {John R.} and Symmons, {D. P M} and Mary Toporcer and Mastrangelo, {Michael J.}",
year = "2010",
month = "2",
doi = "10.1053/j.seminoncol.2010.01.001",
language = "English (US)",
volume = "37",
pages = "11--19",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors

T2 - Does the Risk Justify the Benefit?

AU - Chapman, Paul

AU - Cranmer, Lee D

AU - Dixon, W. G.

AU - Hyrich, K. L.

AU - Patterson, John R.

AU - Symmons, D. P M

AU - Toporcer, Mary

AU - Mastrangelo, Michael J.

PY - 2010/2

Y1 - 2010/2

UR - http://www.scopus.com/inward/record.url?scp=76749164739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76749164739&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2010.01.001

DO - 10.1053/j.seminoncol.2010.01.001

M3 - Article

C2 - 20172358

AN - SCOPUS:76749164739

VL - 37

SP - 11

EP - 19

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 1

ER -